key: cord-0911331-rj0wbsnr
authors: Hullegie, Saskia; Schilder, Anne G. M.; Marchisio, Paola; de Sévaux, Joline L. H.; van der Velden, Alike W.; van de Pol, Alma C.; Boeijen, Josi A.; Platteel, Tamara N.; Torretta, Sara; Damoiseaux, Roger A. M. J.; Venekamp, Roderick P.
title: A Strong Decline in the Incidence of Childhood Otitis Media During the COVID-19 Pandemic in the Netherlands
date: 2021-11-01
journal: Front Cell Infect Microbiol
DOI: 10.3389/fcimb.2021.768377
sha: a3961b786adfac0956fae5fd838efdb8c50ac231
doc_id: 911331
cord_uid: rj0wbsnr

INTRODUCTION: Recent reports have highlighted the impact of the COVID-19 pandemic on the incidence of infectious disease illnesses and antibiotic use. This study investigates the effect of the pandemic on childhood incidence of otitis media (OM) and associated antibiotic prescribing in a large primary care-based cohort in the Netherlands. MATERIAL AND METHODS: Retrospective observational cohort study using routine health care data from the Julius General Practitioners’ Network (JGPN). All children aged 0-12 registered in 62 practices before the COVID-19 pandemic (1 March 2019 - 29 February 2020) and/or during the pandemic (1 March 2020 - 28 February 2021) were included. Data on acute otitis media (AOM), otitis media with effusion (OME), ear discharge episodes and associated antibiotic prescriptions were extracted. Incidence rates per 1,000 child years (IR), incidence rate ratios (IRR) and incidence rate differences (IRD) were compared between the two study periods. RESULTS: OM episodes declined considerably during the COVID-19 pandemic: IR pre-COVID-19 vs COVID-19 for AOM 73.7 vs 27.1 [IRR 0.37]; for OME 9.6 vs 4.1 [IRR 0.43]; and for ear discharge 12.6 vs 5.8 [IRR 0.46]. The absolute number of AOM episodes in which oral antibiotics were prescribed declined accordingly (IRD pre-COVID-19 vs COVID-19: -22.4 per 1,000 child years), but the proportion of AOM episodes with antibiotic prescription was similar in both periods (47% vs 46%, respectively). DISCUSSION: GP consultation for AOM, OME and ear discharge declined by 63%, 57% and 54% respectively in the Netherlands during the COVID-19 pandemic. Similar antibiotic prescription rates before and during the pandemic indicate that the case-mix presenting to primary care did not considerably change. Our data therefore suggest a true decline as a consequence of infection control measures introduced during the pandemic.

On 11 March 2020, the WHO (World Health Organization, 2020) declared a global pandemic of COVID-19 which enforced many countries to introduce generic infection control measures such as wearing face masks, hand washing, social distancing, working from home and closure of schools/daycare centers. Other than reducing SARS-CoV-2 transmission, these generic measures have likely affected transmission of other respiratory viruses (Fricke et al., 2021; Tang et al., 2021) . Since otitis media (OM) is generally preceded by a viral upper respiratory tract infection (URTI) (Schilder et al., 2016) , changes in transmission dynamics of these viruses may have had an impact on the incidence of OM. OM, one of the commonest conditions during early childhood and a prime reason for antibiotic prescriptions (Klein, 2000; Monasta et al., 2012; van den Broek d'Obrenan et al., 2014; Tong et al., 2018) , consists of a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME), and chronic suppurative otitis media (CSOM). AOM is characterized by the presence of middle ear effusion (MEE) with rapid onset of signs and symptoms of an acute infection such as fever and ear pain (Lieberthal et al., 2013) . Approximately 15%-20% of children with AOM present with ear discharge due to a spontaneous tear or perforation of the eardrum Smith et al., 2010) . OME is defined by the presence MEE, without signs and symptoms of an acute infection . Hearing loss is the most common symptom of OME. CSOM is characterized by chronic inflammation of the middle ear and mastoid mucosa together with a non-intact tympanic membrane and persisting ear discharge (Verhoeff et al., 2006) . Several reports from the early phase of the COVID-19 pandemic have suggested a decline in doctor consultations for OM in children (Hatoun et al., 2020; Aldè et al., 2021; Angoulvant et al., 2021; Iannella et al., 2021; Kaur et al., 2021; Torretta et al., 2021; van de Pol et al., 2021) . The question is whether the infection control measures or the sudden COVID-19 related changes in health care access and delivery are responsible for these changes. We will address this question by investigating the effect of the COVID-19 pandemic on OM consultations and associated antibiotic prescribing in children in a large primary care cohort in the Netherlands where the general practitioner (GP) is the first point of call (Grobbee et al., 2005) for the management of OM for all children and practices could be contacted for medical advice throughout the pandemic.

In this retrospective observational cohort study, data were obtained from the Julius General Practitioners' Network (JGPN). Its database contains anonymously extracted routine health care data from electronic records from 62 general practices in the Utrecht area (Smeets et al., 2018) . All children aged 0-12 registered 1 March 2019 -29 February 2020 (pre-COVID-19 pandemic) and/or 1 March 2020 -28 February 2021 (COVID-19 pandemic) were included. The Medical Research Ethics Committee Utrecht has reviewed the study protocol and declared that official ethical approval is not required since this research is outside the scope of the Dutch Medical Research Involving Human Subjects Act (protocol no 21-562/C).

From the electronic health records, GP consultations -both faceto-face as well as telephone consultations -of OM (International Classification of Primary Care [ICPC] code H04 (ear discharge); H71 (acute otitis media) H72 (otitis media with effusion; all episodes, irrespective of preceding GP consultation of AOM) and H01 (ear pain) were extracted. A new OM episode started if there was no OM-related GP consultation for 28 days. For each episode, the start date, the child's age at the start of the episode, the number and type of consultations, antibiotic prescriptions and complications (mastoiditis, ICPC code H74.02) were extracted. OM treated with antibiotics was defined as an OM episode with an oral or topical antibiotic prescription according to the Anatomical Therapeutical Chemical (ATC) classification. Since episodes and antibiotic prescriptions are not directly linked in the JGPN database, antibiotic prescriptions within two days before and after the start and stop date of the episode were captured. The full list of ATC codes used in this study can be found in Supplementary Table 1 . Additionally, data on acute upper respiratory tract infections (URTI, ICPC code R74) were extracted.

On March 15 th 2020, the prime minister of the Netherlands introduced social distancing, working from home, and the closure of restaurants/bars, sport facilitates and schools/ daycare. Primary schools and daycare centres reopened 11 th of May 2020 (Rijksoverheid, 2020) , but a 1.5 meter distance rule remained in place and wearing non-medical face-masks was introduced (both not obligatory for children up to 12 year of age). The second lockdown, including closure of schools and daycare centres, started the December 14 th , 2020 and ended 9 February 9 th , 2021.

We calculated the total number of OM episodes pre-COVID-19 and during the COVID-19 pandemic. Incidence rates (IR) were calculated per 1000 person-years by dividing the number of OM episodes by the total number of person-years in that specific time period. In stratified analyses, children were split into the following age groups: <2 year, 2-6 year and ≥ 6-12 years. Differences in overall OM episodes and those treated with antibiotics between the two time periods were expressed as rate ratios (IRR) and rate differences (IRD) with accompanying 95% confidence intervals (CI). All statistical analyses were performed with SPSS (version 26.0, Chicago, IL, USA) and MedCalc for Windows, version 19.4 (MedCalc Software, Ostend, Belgium). The p-values for IRD were obtained using the Chi-square statistic, while the Exact Mid-P test was used to obtain the p-values for IRR.

In the pre-COVID-19 period, electronic health record data of 67,245 children aged 0-12 years were available (time point: 1 September 2019) whereas data of 67,134 children were available during the pandemic (time point: 1 September 2020). Sex and age distribution were similar across periods: 51% male, 16% aged <2 years, 33% 2-6 years and 51% ≥ 6-12 years.

OM episodes declined considerably during the COVID-19 pandemic ( Figure 1) and age-specific analyses revealed similar results, except for a less pronounced decline in OME episodes in children aged 0-2 years [IRD -0.66, 95% CI -2.50-1.18]. Figure 1 shows the monthly incidences of AOM episodes per 1,000 child months for various age groups before and during the pandemic and illustrates the absence of the usual winter peak in AOM incidence during the COVID-19 pandemic, especially in young children. Supplementary Figure 2 shows the monthly incidence of OME episodes per 1,000 child months for various age before and during the pandemic. Figure 2 illustrates the timing of implementation of generic infection control measures together with the monthly incidences of AOM and OME per 1,000 child months from March 2019 to March 2021. AOM and OME incidences decrease sharply during the COVID-19 peaks as well as during closure of schools and daycare centers. Acute upper respiratory tract infections show a similar pattern (Supplementary Figure 3) .

Similar to the overall OM episodes, the absolute number of AOM episodes in which oral antibiotics were prescribed declined accordingly (IRD pre-COVID-19 vs COVID-19: -22.4 per 1,000 child years), but the proportion of AOM episodes with antibiotic prescription was similar in both periods (47% vs 46%, respectively) ( Table 1) .

The numbers of OM-episodes are based on ICPC-codes, which consist of both face-to-face and telephone GP consultations. The proportion of OM episodes (AOM, OME, ear discharge combined) which were coded based on only telephone consultation(s) only, increased over time [pre-COVID-19 vs COVID-19: 7.4% vs 22.3%].

The incidence of acute mastoiditis remained low throughout the study period; IR per 1,000 child year pre-COVID-19 vs COVID-19: 0.15 vs 0.10 [RR 0.70, 95% 0.23-2.04].

This large retrospective cohort study showed that GP consultation for AOM, OME and ear discharge declined by 63%, 57% and 54% respectively in the Netherlands during the COVID-19 pandemic.

Previous studies in other countries have reported a similar trend in childhood OM incidence during the first COVID-19 peak (Hatoun et al., 2020; Aldè et al., 2021; Angoulvant et al., 2021; Iannella et al., 2021; Torretta et al., 2021) . Under normal circumstances, OM typically shows a seasonal pattern with a winter peak coinciding with the increase in URTI incidence (Castagno and Lavinsky, 2002) . Our study demonstrates the absence of the usual winter peak in AOM and OME during COVID-19 which is comparable with the reports of bronchiolitis from Belgium (Van Brusselen et al., 2021) . The observed reduction in childhood OM might be attributed to the generic infection control measures, or changes in health care access and delivery. Although primary care services in the Netherlands remained accessible during the pandemic, the measures could have led to a higher threshold for consulting the GP, particularly early in the pandemic.

We found no evidence of an increase in the proportion of childhood OM episodes treated with antibiotics despite a substantial reduction in GP consultations for OM. This suggests that the observed decline in doctor consultations for OM was not related to OM severity and therefore not primarily attributed to a higher threshold to consultation. In line with our Incidence rate = total episodes per 1000 persons years. c Percentage of episodes with an oral antibiotic prescriptions, including amoxicillin, amoxicillin/clavulanic-acid, co-trimoxazole, clarithromycin, azithromycin. d Percentage of episodes with a topical antibiotic prescriptions, including tobramycin, ofloxacin, dexamethasone/tobramycin, dexamethasone/framycetine/gramicidin, hydrocortisone/ colistin/bacitracin. e Incidence Rate ratios (IRR) and Incidence Rate differences (IRD) per episode (Pre COVID-19 era vs COVID-19 era), including 95% confidence interval. f IRD episodes with an oral antibiotic prescription per 1000 persons years (Pre COVID-19 era vs COVID-19 era), including 95% confidence interval. g IRD episodes with a topical antibiotic prescription per 1000 persons years (Pre COVID-19 era vs COVID-19 era), including 95% confidence interval.

findings, a previous study in Scotland reported that the COVID-19 lockdown led to a decline in pediatric emergency care consultations without an associated increase in severity (Williams et al., 2021) . Another recent study in the United States has also found a lower rate in respiratory infection visits around September 2020 likely attributed to the infection control measures.

The major strengths of our study are its large sample size using well-documented electronic routine primary care-based health care data. The longitudinal nature of our study allowed us to compare the same study population within the same practices during two full years, i.e. one full year pre-COVID-19 and a complete year during the COVID-19 pandemic. Some methodological limitations need to be considered. First, misclassification might have occurred. Particularly during the COVID-19 pandemic, a substantial proportion of OM diagnoses were based on telephone consultation only which could have led to misclassification in OM diagnosis. A previous study from our group found that only 50% of parentreported OM (fever and ear pain) episodes led to a GP diagnosis of OM (Fortanier et al., 2015) .However, despite the increase in telephone consultations, we found a decline in the ICPC code 'ear pain' as well. This suggests that our observations reflect a true decline of OM during the pandemic. Moreover, misclassification might have occurred for the ICPC code 'ear discharge' since we were unable to determine whether this related to an acute onset of ear discharge or chronic suppurative otitis media. Furthermore, some children presenting with AOM and ear discharge will likely be classified by their GP as 'AOM' [ICPC code H71], i.e. those with AOM who were prescribed topical antibiotics. Second, we were unable to reliably extract data on specialist referrals and data about out of hours primary care were not available. Therefore, our results regarding complications should be interpreted with caution. Reassuringly, a previous study from Italy did not find a significant difference in OMrelated complications during the first COVID-19 wave (Torretta et al., 2021 ) Finally, we were not able to link reductions in childhood AOM episodes to changes in causative viruses and bacteria over time. Such data would have allowed us to better explain our observations.

The observed decline in OM incidence similar to those observed in other common respiratory infections during the COVID-19 pandemic (Hatoun et al., 2020; Angoulvant et al., 2021; Kaur et al., 2021; Barschkett et al., 2021) providing further evidence for social interactions an hygiene as risk factors for OM. Continuing infection control measures like frequent handwashing (Little et al., 2015) may have a lasting effect on OM incidence beyond COVID-19 pandemic.

Although we should keep in mind the importance of social contacts in the development of children when considering implementing these infection control measures.

FIGURE 1 | Incidence of AOM episodes per 1,000 childmonths (total and according to age) pre-COVID-19 era and COVID-19 era.

GP consultation for AOM, OME and ear discharge declined by 63%, 57% and 54% respectively in the Netherlands during the COVID-19 pandemic. Similar antibiotic prescription rates before and during the pandemic indicate that the case-mix presenting to primary care did not change considerably. Our data therefore suggests a true decline as a consequence of infection control measures introduced during the pandemic.

The data analyzed in this study is subject to the following licenses/restrictions: Data are not publicly available due to ethical and legal restrictions. Requests to access these datasets should be directed to not applicable.

Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent from the participants' legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements. 

Effects of COVID-19 Lockdown on Otitis Media With Effusion in Children: Future Therapeutic Implications

Otolaryngol Head Neck Surg

Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-A Time Series Analysis

COVID-19 Associated Contact Restrictions in Germany: Marked Decline in Children's Outpatient Visits for Infectious Diseases Without Increasing Visits for Mental Health Disorders

Otitis Media in Children: Seasonal Changes and Socioeconomic Level

Parent-Reported Symptoms of Acute Otitis Media During the First Year of Life: What is Beneath the Surface?

Impact of non-Pharmaceutical Interventions Targeted at COVID-19 Pandemic on Influenza Burden -a Systematic Review

The Utrecht Health Project: Optimization of Routine Healthcare Data for Research

Social Distancing for COVID-19 and Diagnoses of Other Infectious Diseases in Children

Impact of COVID-19 Pandemic on the Incidence of Otitis Media With Effusion in Adults and Children: A Multicenter Study

COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children

The Burden of Otitis Media

Clinical Practice Guideline: The Diagnosis and Management of Acute Otitis Media

An Internet-Delivered Handwashing Intervention to Modify Influenza-Like Illness and Respiratory Infection Transmission (PRIMIT): A Primary Care Randomised Trial

Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates

Basisscholen Vanaf 11 Mei Aangepast Open

Clinical Practice Guideline: Otitis Media With Effusion (Update)

Antibiotics for Acute Otitis Media: A Meta-Analysis With Individual Patient Data

Otitis Media

Routine Primary Care Data for Scientific Research, Quality of Care Programs and Educational Purposes: The Julius General Practitioners' Network (JGPN)

Ear Discharge in Children Presenting With Acute Otitis Media: Observational Study From UK General Practice

Where Have All the Viruses Gone? Disappearance of Seasonal Respiratory Viruses During the COVID-19 Pandemic

Trends in Healthcare Utilization and Costs Associated With Acute Otitis Media in the United States During

Incidental Lowering of Otitis-Media Complaints in Otitis-Prone Children During COVID-19 Pandemic: Not All Evil Comes to Hurt

Antibiotic Use in Dutch Primary Care: Relation Between Diagnosis, Consultation and Treatment

Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in The Netherlands: A Primary Care-Based Observational Cohort Study

Chronic Suppurative Otitis Media: A Review

Indirect Effects of the COVID-19 Pandemic on Paediatric Healthcare Use and Severe Disease: A Retrospective National Cohort Study

World Health Organization WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 -11

this article, or claim that may be made by its manufacturer, is not guaranteed or

We would like to thank the general practitioners for sharing their anonymous patient care data with the Julius General Practitioners' Network.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2021.768377/ full#supplementary-material Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in